We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$16.8B
AUM Growth
+$2.43B
(+17%)
Cap. Flow
+$2.2B
Cap. Flow
% of AUM
13.07%
Top 10 Holdings %
Top 10 Hldgs %
12.03%
Holding
1,764
New
564
Increased
341
Reduced
326
Closed
526
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.58% |
| 3 | Consumer Staples | 7.89% |
| 4 | Financials | 7.87% |
| 5 | Healthcare | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
576
CALL
DELISTED
Endo International plc
ENDP
| $4.22M | 0.03% |
+150,000
| New | +$7.08M |
|
|
CSOD
577
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $4.17M | 0.02% |
+127,105
| New | +$3.83M |
|
|
PGRE
578
DELISTED
Paramount Group
PGRE
| $4.16M | 0.02% |
261,083
-336,774
| -56% | -$5.38M |
|
579
Caesars Entertainment
CZR
$6.14B
| $4.14M | 0.02% |
361,877
+12,864
| +4% | +$134K |
|
580
SiriusPoint
SPNT
$2.68B
| $4.13M | 0.02% |
363,720
+11,118
| +3% | +$126K |
|
|
CHK
581
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $4.12M | 0.02% |
+5,000
| New | +$3.54M |
|
582
PUT
Baxter International
BAX
$14.2B
| $4.11M | 0.02% |
+100,000
| New | +$3.81M |
|
|
ULTI
583
DELISTED
Ultimate Software Group Inc
ULTI
| $4.08M | 0.02% |
21,068
-4,474
| -18% | -$778K |
|
|
FPRX
584
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.07M | 0.02% |
100,250
-125,552
| -56% | -$4.32M |
|
585
PUT
Sanofi
SNY
$104B
| $4.02M | 0.02% |
+100,000
| New | +$4.02M |
|
586
CALL
Ciena
CIEN
$58.4B
| $4.01M | 0.02% |
+211,100
| New | +$3.9M |
|
|
587
PUT
Teva Pharmaceuticals
TEVA
$41.2B
| $4.01M | 0.02% |
+75,000
| New | +$4.4M |
|
588
Boston Beer
SAM
$1.92B
| $4.01M | 0.02% |
21,646
-27,470
| -56% | -$5.01M |
|
|
PDCO
589
DELISTED
Patterson Companies, Inc.
PDCO
| $4M | 0.02% |
85,918
-1,044,778
| -92% | -$45.2M |
|
590
Agios Pharmaceuticals
AGIO
$1.93B
| $4M | 0.02% |
98,450
+10,950
| +13% | +$468K |
|
|
MRC
591
DELISTED
MRC Global
MRC
| $3.98M | 0.02% |
+303,300
| New | +$3.49M |
|
|
ETP
592
DELISTED
Energy Transfer Partners L.p.
ETP
| $3.93M | 0.02% |
+121,500
| New | +$3.39M |
|
593
Abercrombie & Fitch
ANF
$5B
| $3.91M | 0.02% |
124,060
-403,309
| -76% | -$11.3M |
|
594
Energy Recovery
ERII
$443M
| $3.89M | 0.02% |
376,438
+128,687
| +52% | +$938K |
|
595
Las Vegas Sands
LVS
$29.6B
| $3.88M | 0.02% |
+75,000
| New | +$3.43M |
|
596
RenaissanceRe
RNR
$13.4B
| $3.87M | 0.02% |
32,300
+1,664
| +5% | +$189K |
|
597
Essent Group
ESNT
$6.33B
| $3.83M | 0.02% |
184,380
-81,550
| -31% | -$1.56M |
|
598
Revvity
RVTY
$12.8B
| $3.8M | 0.02% |
76,817
+69,747
| +987% | +$3.33M |
|
|
DOC
599
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.8M | 0.02% |
+204,366
| New | +$3.52M |
|
|
CPPL
600
DELISTED
Columbia Pipeline Partners LP
CPPL
| $3.75M | 0.02% |
+257,102
| New | +$3.95M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Balyasny Asset Management held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Balyasny Asset Management deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Balyasny Asset Management's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Balyasny Asset Management added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Balyasny Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Balyasny Asset Management fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Balyasny Asset Management's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Balyasny Asset Management opened 564 new positions and closed 526 in Q1 2016.
- Balyasny Asset Management's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.